Venture Kapital

CVX Ventures Online Partner meeting

At this partner meeting, a number of companies will be presented that you can join as advisory board members and/or invest in. The companies will be announced progressively.

Read About the Cases

HEKA VR

Heka VR advances mental health care with evidence-based therapies for auditory hallucinations, focusing on treatment-resistant schizophrenia. Using VR and real-time voice modulation, it offers a unique, patient-centered approach. Initially a project with Danish healthcare regions, funded by Innovation Fund Denmark and BioInnovation Institute, Heka VR spun off from Khora Virtual Reality to empower patients and drive global mental health research.

Heka VR completed a successful clinical trial in Denmark and is conducting 11 pilots globally, including in the USA, Canada, and Australia. National implementation in Denmark is planned for 2025-2026. The company has secured €2.145 million in funding from organizations like Innovationsfonden, BioInnovation Institute, and the EU Commission.

Heka VR is seeking a candidate with expertise in AI, machine learning, funding, investor networks, management, marketing, and go-to-market strategies to drive its innovative mental health solutions.

ReHuman

Rehuman, a UK Insurtech founded in May 2024, offers an AI-powered health and wellness platform for the private health insurance sector. Integrating wearable and clinical data, it delivers personalized wellbeing plans and disease prevention. For insurers and corporates, it enhances predictive health risk, reduces reactive claims, and lowers premiums and sick day costs. Rehuman aims to stand out with a multi-carrier marketplace and a rewards system to boost adoption and retention.

Rehuman has partnered with leading insurers like AVIVA, working with their Chief Medical Officer and Head of Innovation to secure their role in the Rehuman marketplace. The pipeline includes WellX (Dubai), Hunter Healthcare (UK), LifeRewards (UK), Standard Chartered Bank (Singapore), and Accenture (UK & Nordics).

Rehuman is raising £1m in equity at a pre-money valuation of £4m. The cap table post-round allocates 71% to founders, 9% to the option pool, and 20% to investors, including Fuel Ventures, Accenture Ventures, and angels. CVX investors have a £200k allocation via an SPV, with a minimum ticket of £1k. The company has no debt, a £40k monthly burn, and targets profitability by Q4 2026. Proceeds will fund Recoach and an insurance marketplace, preparing for scalability with clients like Accenture. An exit is expected in 4-5 years via acquisition by global health insurers

Luminy

Luminy, a Swedish company, revolutionizes AR management with predictive technology and team collaboration. Their platform predicts payment delays, offers actionable strategies, and integrates seamlessly with financial systems to improve cash flow and reduce overdue payments.

Since Q2 2024, Luminy has made significant strides, conducting 30+ CFO interviews, partnering with Knowit, launching four pilots, and raising €200K in funding. Plans include adding payment checkout functionality to streamline transactions. Backed by an expert team with experience in equity markets, corporate strategy, and senior tech roles from Spotify, Luminy is set for continued growth.
 

Luminy is seeking a candidate with expertise in B2B sales, go-to-market strategy, and scaling to drive the growth of its innovative AR management platform.

HILI

HILI is a Norwegian investment firm that offers a unique approach to homeownership. Homeowners can sell a share of their property to HILI, while retaining full access to their entire home. They also have the option to buy back the share at a later time. The agreement between the homeowner and HILI is a genuine co-ownership, which is legally registered. This solution is not a loan or credit. Homeowners continue to benefit from a growing housing market. With HILI, owning a home no longer requires full ownership; you can now own a portion of a home instead of none at all. HILI’s revenue comes from Asset Management fees paid by house owners and potential upside from homeowners and HILI selling their properties at a higher price.

HILI generates revenue through three streams: one-off establishment fees from homeowners, annual management fees on total AuM, and commissions from mortgages, insurance, and other services. Since its late 2023 launch, HILI has gained significant traction as Europe’s first mover, with €200m in potential deals from 600+ waitlisted customers without marketing spend. They aim to raise €25m by Q1 2025 and plan to deploy €13m across 75+ home investments in the Nordics in 2025. Over five years, they project €2.5bn invested in 12k properties.

Hili is raising €1.3m (NOK 15m) in equity at a pre-money valuation of €11.6m (NOK 135m), launched in November 2024. The cap table allocates 75% to founders, 8% to the board, and 17% to private investors. CVX investors have a €200k (NOK 2.3m) allocation via an SPV, with a minimum ticket of €850 (NOK 10k). A prior raise in 2024 secured €850k (NOK 10m) at a €3.1m (NOK 36m) valuation. The company has a runway through December 2025, a monthly burn of NOK 1.68m, and NOK 3.8m in cash. EBITDA-positive is targeted for November 2027

Nordic Harvest

Nordic Harvest is at the forefront of sustainable agriculture, specializing in vertical farming that cultivates crops in stacked layers within a controlled environment. This cutting-edge approach allows for precise control over plant growth conditions, resulting in higher yields and superior product quality. By significantly reducing the need for arable land and water, vertical farming offers a sustainable and efficient alternative to traditional farming practices. As climate change increasingly disrupts global agriculture, Nordic Harvest’s innovative methods provide a resilient solution to meet the growing demand for reliable and sustainable food production.

Nordic Harvest has proven its concept with a high-performing organization and a pharmaceutical-grade quality system, ensuring consistent output and minimal losses. In 3.5 years, it has scaled production, supplying the Salling Group, with 37 FTEs and projected revenue of DKK 10 million this year. Backed by DKK 120 million from private investors, the company developed a fully automated facility to cut costs and boost yield. With 70% of expanded production secured under a five-year contract, Nordic Harvest is poised for growth and profitability.

Nordic Harvest is looking for a candidate with expertise in internationalization, sales, and market entry strategy, platform development, and experience in agri-food tech, ESG, construction, and properties.

Poulsen Motors

Poulsen Motorcycles, headquartered in Denmark, designs and produces electric motorcycles that merge cutting-edge technology with sustainable production. Their innovative, modular designs allow for easy customization and even compact storage in a suitcase, making them ideal for modern, on-the-go lifestyles. By skipping traditional assembly lines, Poulsen partners with local dealers for assembly, ensuring high efficiency and quality control. Priced at 250,000 DKK, these motorcycles offer a unique blend of high performance, adaptability, and convenience, redefining the riding experience for today’s motorcyclists.

Poulsen’s prototype has impressed industry experts and consumers with its 200 kg weight, 300 km range, 200 km/h top speed, and 30-minute CCS fast charging. Backed by Letters of Intent from sales partners and collaborations with Asger Simonsen, Omfang, and tech partner Abtery, Poulsen is ready for product certification and a strong market launch.

Poulsen Motorcycles seeks a candidate with expertise in go-to-market strategies, scaling, funding, finance, legal, ESG, consumer goods, and marketing to drive its innovative and sustainable electric motorcycle vision.

Kieku AI Tools

Kieku AI Tools, based in Helsinki, revolutionizes music production with intuitive AI-powered tools like The Bass Player, The Drummer, and The Riff Maker. Designed for seamless DAW integration and copyright compliance, Kieku enables real-time composition for musicians of all levels. Its technology extends to film and media, creating dynamic soundtracks and facilitating collaborations with AI-powered iconic musicians.

Kieku has launched a web app for its “Prediction Model,” enabling real-time improvisation with AI. MVP testing showed 77% user satisfaction for its intuitive design. The company secured second place at BIME and presented ethical AI practices at the UN. Targeting 5,000 subscribers from 70M global music creators, Kieku aims for $600,000 ARR, with plans to expand into film and gaming, supported by Aalto University partnerships. Its published research on real-time generative music models solidifies its leadership in AI-driven music innovation.

Kieku AI Tools is looking for a candidate with expertise in business management (CEO-level experience), go-to-market strategy, and fundraising to help drive its innovative vision forward.

Mello

Microencapsulation is increasingly essential across industries for effectively delivering active ingredients in products. However, current methods are often inefficient, wasteful, and reliant on non-eco-friendly materials. Mello’s innovative solution addresses these challenges, delivering active ingredients efficiently using only eco-friendly materials with no harmful waste. Their scalable and commercially viable technology is tailored for key sectors such as Wellness, Personal Care, and Pharma.

Mello has attracted strong industry interest and is nearing a commercial agreement with a key player. They have raised 14 million DKK through BII programs, 2 million from Innovationsfonden, and earned 3rd prize in the EIT Food Fan accelerator. Mello’s robust IP portfolio includes a published patent (‘encapsulated core material’) and another in the PCT phase, both with freedom-to-operate confirmed and fully owned by the company, ensuring full control over their innovations.

Mello is seeking candidates with expertise in biotechnology, pharmaceuticals, drug delivery, encapsulation technologies, and go-to-market strategies in pharma and wellness. Their eco-friendly, scalable microencapsulation technology targets sectors like Wellness, Personal Care, and Pharma, addressing inefficiencies and eliminating harmful waste.

Find ud af, om CVX er et match for din virksomhed

Du skal blot udfylde nedenstående felter, og så tager vi kontakt hurtigst muligt ift. den kommende proces.

Picture of Har du spørgsmål?

Har du spørgsmål?

Så er du velkommen til at kontakte Investment Manager, Sara Nahon, på sn@cvx.vc.

Få et møde

Hvis du har spørgsmål til, hvordan vi investerer eller hjælper med bestyrelsesposter, så kan du booke et møde herunder: 

Picture of Spørgsmål omkring bestyrelse?

Spørgsmål omkring bestyrelse?

Oscar Thybo, Senior Manager of Board & Advisory

Få et møde →
Picture of Spørgsmål omkring partnere?

Spørgsmål omkring partnere?

Joakim Herrestrup, Head of Partner Relations

Få et møde →

Discover if CVX is a match for your startup business

Simply fill out the fields below and we’ll get back to you as soon as possible. the upcoming process.

Picture of Do you have any questions?

Do you have any questions?

Please contact Investment Manager, Sara Nahon, at sn@cvx.vc.

Get a meeting

If you have questions about how we invest or help with board positions, you can book a meeting below:

Picture of Questions about the board?

Questions about the board?

Katrine Gilberg , Head of Board & Advisory

Get a meeting →
Picture of Questions about partners?

Questions about partners?

Joakim Herrestrup, Head of Partner Relations

Get a meeting →